Status: Recruiting
The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4
Study goals 1. Prospective longitudinal data on progression in the natural course of SPG4 in presymptomatic mutation carriers prior to clinical disease onset and in early stages of disease 2. Biomarkers providing objective measures of disease activity
Participants needed: 200
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: University Hospital TuebingenUpdated: Aug 23, 2022Locations: 1
Eligibility criteria
First degree relatives (parents, offspring, and sibs) of SPG4 patients or sympto... [+2]
No known SPAST-mutation within the family [+2]